ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645998 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645998; 2) Community: the network communities that were significantly associated with the response to NSC 645998; 3) Molecule: the relationships between components within communities and NSC 645998; 4) MDR: the compounds that were significantly associated with the NSC 645998.

NSC Compound Enrichment Correlation
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0235234559682125 0.2491337
NSC 244404 Null 0.0235234559682125 0.25545488
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0235234559682125 0.48276558
NSC 300289 Pinafide 0.0235234559682125 0.11198472
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0235234559682125 0.53257535
NSC 30915 Null 0.0235234559682125 0.44110943
NSC 328410 Camptothecin Derivative 0.0235234559682125 0.037434939
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0235234559682125 0.34483265
NSC 359239 Antibiotic X-14766A 0.0235234559682125 0.11999488
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0235234559682125 0.26478348
Total:112  Current:66    [First] [Prev] [Next] [Last]